Biogen is a Massachusetts-based biotechnology company that discovers, develops, and commercializes drugs for the treatment of neurological diseases.Read more
Biogen's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 34.4B. Over the last four quarters, Biogen's revenue has decreased by 8.8%. Specifically, in Q1 2022's revenue was $2.5B; in Q4 2021, it was $2.7B; in Q3 2021, it was $2.8B; in Q2 2021, Biogen's revenue was $2.8B.